WinstonWınston
Back
AllStar Health Brands logo

AllStar Health Brands

ALST
Medical - Pharmaceuticals · Healthcare
Price
$0.00
+0.00 (+0.00%)
Market Cap
$128,451
Exchange
Other OTC
Winston Score
Winston looking sleepy
No score yet — Winston is napping.
We couldn’t gather enough financial data to score this stock reliably.

Share count rising — dilution

+1113.8% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 26.5M (2021) → 321.1M (2025)

Winston Score History

The full picture

AllStar Health Brands Inc is a small pharmaceutical and health products company. It focuses on developing and selling branded health and wellness products, which may include over-the-counter medicines, supplements, or consumer health items. The company operates in the broader healthcare and pharmaceuticals space, targeting everyday consumers looking for health-related products.

The company generates revenue through product sales, likely through retail channels or direct distribution. With a market cap near zero and margins that are not yet measurable in public data, AllStar Health Brands appears to be a very early-stage or micro-cap business with limited financial scale. The main risk facing the company is its small size, which makes it vulnerable to cash flow problems, competition from larger pharmaceutical brands, and difficulty gaining shelf space or consumer awareness in a crowded health products market.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

+100.0% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

Research and development spending

Insider Activity

0.0%ownership

Relatively low insider ownership

Cash Runway

~0 months

$165 cash & investments

Short runway — potential dilution ahead through share issuance

Cash watch

AllStar Health Brands has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
N/A
Data not available
Profit after running costs
Operating Margin
N/A
Data not available
Return on the money invested
ROCE
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
N/A
Data not available
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
N/A
Data not available
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial